Stadlofen 50 Contraindications

STADLOFEN 50 GASTRO-RESISTANT TABLETS 50MG is contraindicated in: Patients with a known hypersensitivity to the active ingredient or to any of the excipients; Patients with active, gastric or intestinal ulcer, bleeding or perforation; Patients with history of gastrointestinal bleeding or perforation, relating to previous NSAIDs therapy; Patients with active, or history of recurrent peptic ulcer/haemorrhage (two or more distinct episodes of proven ulceration or bleeding); The third trimester of pregnancy, because of risks of premature closure of the ductus arteriosus and prolonged parturition; Patients with hepatic failure; Patients with renal failure; Established congestive heart failure (NYHA II-IV), ischemic heart disease, peripheral arterial disease and/or cerebrovascular disease; Patients in whom attacks of asthma, angioedema, urticaria or acute rhinitis are precipitated by ibuprofen, acetylsalicylic acid or other non-steroidal anti-inflammatory drugs; Patients with severe heart failure; Treatment of peri-operative pain in the setting of coronary artery bypass graft surgery.